TY - JOUR
T1 - Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis
T2 - A Mendelian Randomization Study
AU - Ellervik, Christina
AU - Mora, Samia
AU - Kus, Aleksander
AU - Asvold, Bjorn
AU - Marouli, Eirini
AU - Deloukas, Panos
AU - Sterenborg, Rosalie B. T. M.
AU - Teumer, Alexander
AU - Burgess, Stephen
AU - Sabater-Lleal, Maria
AU - Huffman, Jennifer
AU - Johnson, Andrew D.
AU - Tregouet, David-Alexandre
AU - Smith, Nicolas L.
AU - Medici, Marco
AU - DeVries, Paul S.
AU - Chasman, Daniel I.
AU - Kjaergaard, Alisa D.
PY - 2021
Y1 - 2021
N2 - Background: Untreated hypothyroidism is associated with acquired von Willebrand syndrome, and hyperthyroidism is associated with increased thrombosis risk. However, the causal effects of thyroid function on hemostasis, coagulation, and fibrinolysis are unknown. Methods: In a two-sample Mendelian randomization (MR) study with genome-wide association variants, we assessed causality of genetically predicted hypothyroidism (N = 134,641), normal-range thyrotropin (TSH; N = 54,288) and free thyroxine (fT4) (N = 49,269), hyperthyroidism (N = 51,823), and thyroid peroxidase antibody positivity (N = 25,821) on coagulation (activated partial thromboplastin time, von Willebrand factor [VWF], factor VIII [FVIII], prothrombin time, factor VII, fibrinogen) and fibrinolysis (D-dimer, tissue plasminogen activator [TPA], plasminogen activator inhibitor-1) from the CHARGE Hemostasis Consortium (N = 2583-120,246). Inverse-variance-weighted random effects were the main MR analysis followed by sensitivity analyses. Two-sided p < 0.05 was nominally significant, and p < 0.0011[ = 0.05/(5 exposures x 9 outcomes)] was Bonferroni significant for the main MR analysis. Results: Genetically increased TSH was associated with decreased VWF [beta(SE) = -0.020(0.006), p = 0.001] and with decreased fibrinogen [beta(SE) = -0.008(0.002), p = 0.001]. Genetically increased fT4 was associated with increased VWF [beta(SE) = 0.028(0.011), p = 0.012]. Genetically predicted hyperthyroidism was associated with increased VWF [beta(SE) = 0.012(0.004), p = 0.006] and increased FVIII [beta(SE) = 0.013(0.005), p = 0.007]. Genetically predicted hypothyroidism and hyperthyroidism were associated with decreased TPA [beta(SE) = -0.009(0.024), p = 0.024] and increased TPA [beta(SE) = 0.022(0.008), p = 0.008], respectively. MR sensitivity analyses showed similar direction but lower precision. Other coagulation and fibrinolytic factors were inconclusive. Conclusions: In the largest genetic studies currently available, genetically increased TSH and fT4 may be associated with decreased and increased synthesis of VWF, respectively. Since Bonferroni correction may be too conservative given the correlation between the analyzed traits, we cannot reject nominal associations of thyroid traits with coagulation or fibrinolytic factors.
AB - Background: Untreated hypothyroidism is associated with acquired von Willebrand syndrome, and hyperthyroidism is associated with increased thrombosis risk. However, the causal effects of thyroid function on hemostasis, coagulation, and fibrinolysis are unknown. Methods: In a two-sample Mendelian randomization (MR) study with genome-wide association variants, we assessed causality of genetically predicted hypothyroidism (N = 134,641), normal-range thyrotropin (TSH; N = 54,288) and free thyroxine (fT4) (N = 49,269), hyperthyroidism (N = 51,823), and thyroid peroxidase antibody positivity (N = 25,821) on coagulation (activated partial thromboplastin time, von Willebrand factor [VWF], factor VIII [FVIII], prothrombin time, factor VII, fibrinogen) and fibrinolysis (D-dimer, tissue plasminogen activator [TPA], plasminogen activator inhibitor-1) from the CHARGE Hemostasis Consortium (N = 2583-120,246). Inverse-variance-weighted random effects were the main MR analysis followed by sensitivity analyses. Two-sided p < 0.05 was nominally significant, and p < 0.0011[ = 0.05/(5 exposures x 9 outcomes)] was Bonferroni significant for the main MR analysis. Results: Genetically increased TSH was associated with decreased VWF [beta(SE) = -0.020(0.006), p = 0.001] and with decreased fibrinogen [beta(SE) = -0.008(0.002), p = 0.001]. Genetically increased fT4 was associated with increased VWF [beta(SE) = 0.028(0.011), p = 0.012]. Genetically predicted hyperthyroidism was associated with increased VWF [beta(SE) = 0.012(0.004), p = 0.006] and increased FVIII [beta(SE) = 0.013(0.005), p = 0.007]. Genetically predicted hypothyroidism and hyperthyroidism were associated with decreased TPA [beta(SE) = -0.009(0.024), p = 0.024] and increased TPA [beta(SE) = 0.022(0.008), p = 0.008], respectively. MR sensitivity analyses showed similar direction but lower precision. Other coagulation and fibrinolytic factors were inconclusive. Conclusions: In the largest genetic studies currently available, genetically increased TSH and fT4 may be associated with decreased and increased synthesis of VWF, respectively. Since Bonferroni correction may be too conservative given the correlation between the analyzed traits, we cannot reject nominal associations of thyroid traits with coagulation or fibrinolytic factors.
KW - coagulation
KW - fibrinolysis
KW - hemostasis
KW - hyperthyroidism
KW - hypothyroidism
KW - thyroid hormone
KW - thyroid peroxidase antibody
KW - thyrotropin
KW - TISSUE-PLASMINOGEN-ACTIVATOR
KW - PARTIAL THROMBOPLASTIN TIME
KW - GENOME-WIDE ASSOCIATION
KW - CARDIOVASCULAR EVENTS
KW - VENOUS THROMBOSIS
KW - FREE-THYROXINE
KW - RISK
KW - HYPERTHYROIDISM
KW - INSTRUMENTS
KW - HYPOTHYROIDISM
U2 - 10.1089/thy.2021.0055
DO - 10.1089/thy.2021.0055
M3 - Journal article
C2 - 34210154
VL - 31
SP - 1305
EP - 1315
JO - Thyroid
JF - Thyroid
SN - 1050-7256
IS - 9
ER -